AAAAAA

   
Results: 1-25 | 26-50 | 51-66
Results: 1-25/66
HEMOSTATIC SYSTEM ACTIVATION AND PREDICTION OF VASCULAR EVENTS IN PATIENTS PRESENTING WITH STABLE PERIPHERAL ARTERIAL-DISEASE OF MODERATE SEVERITY
Authors: BONEU B LEGER P ARNAUD C
Citation: B. Boneu et al., HEMOSTATIC SYSTEM ACTIVATION AND PREDICTION OF VASCULAR EVENTS IN PATIENTS PRESENTING WITH STABLE PERIPHERAL ARTERIAL-DISEASE OF MODERATE SEVERITY, Blood coagulation & fibrinolysis, 9(2), 1998, pp. 129-135
AGING AND VENOUS THROMBOEMBOLISM INFLUENCE THE PHARMACODYNAMICS OF THE ANTI-FACTOR XA AND ANTI-THROMBIN ACTIVITIES OF A LOW-MOLECULAR-WEIGHT HEPARIN (NADROPARIN)
Authors: MISMETTI P LAPORTESIMITSIDIS S NAVARRO C SIE P DAZEMAR P NECCIARI J DURET JP GAUD C DECOUSUS H BONEU B
Citation: P. Mismetti et al., AGING AND VENOUS THROMBOEMBOLISM INFLUENCE THE PHARMACODYNAMICS OF THE ANTI-FACTOR XA AND ANTI-THROMBIN ACTIVITIES OF A LOW-MOLECULAR-WEIGHT HEPARIN (NADROPARIN), Thrombosis and haemostasis, 79(6), 1998, pp. 1162-1165
PHARMACODYNAMICS AND TOLERANCE OF 2 NADROPARIN FORMULATIONS (10,250 AND 20,500 ANTI XA IU-ML(-1)) DELIVERED FOR 10 DAYS AT THERAPEUTIC DOSE
Authors: BONEU B NAVARRO C CAMBUS JP CAPLAIN H DAZEMAR P NECCIARI J DURET JP GAUD C SIE P
Citation: B. Boneu et al., PHARMACODYNAMICS AND TOLERANCE OF 2 NADROPARIN FORMULATIONS (10,250 AND 20,500 ANTI XA IU-ML(-1)) DELIVERED FOR 10 DAYS AT THERAPEUTIC DOSE, Thrombosis and haemostasis, 79(2), 1998, pp. 338-341
A NEW METHOD FOR QUANTIFYING PLATELET DEPOSITION IN FLOWING NATIVE BLOOD IN AN EX-VIVO MODEL OF HUMAN THROMBOGENESIS
Authors: BOSSAVY JP SAKARIASSEN KS BARRET A BONEU B CADROY Y
Citation: Jp. Bossavy et al., A NEW METHOD FOR QUANTIFYING PLATELET DEPOSITION IN FLOWING NATIVE BLOOD IN AN EX-VIVO MODEL OF HUMAN THROMBOGENESIS, Thrombosis and haemostasis, 79(1), 1998, pp. 162-168
ARACHIDONIC-ACID ENHANCES THE TISSUE FACTOR EXPRESSION OF MONONUCLEAR-CELLS BY THE CYCLO-OXYGENASE-1 PATHWAY - BENEFICIAL EFFECT OF N-3 FATTY-ACIDS
Authors: CADROY Y DUPOUY D BONEU B
Citation: Y. Cadroy et al., ARACHIDONIC-ACID ENHANCES THE TISSUE FACTOR EXPRESSION OF MONONUCLEAR-CELLS BY THE CYCLO-OXYGENASE-1 PATHWAY - BENEFICIAL EFFECT OF N-3 FATTY-ACIDS, The Journal of immunology, 160(12), 1998, pp. 6145-6150
POLYMORPHONUCLEAR LEUKOCYTES (PMN) EXERT OPPOSITE REGULATORY EFFECTS ON TISSUE FACTOR (TF) PRODUCTION BY MONOCYTES (M) - ROLE OF REACTIVE OXYGEN SPECIES (ROS)
Authors: CADROY Y DUPOUY D BONEU B PLAISANCE H
Citation: Y. Cadroy et al., POLYMORPHONUCLEAR LEUKOCYTES (PMN) EXERT OPPOSITE REGULATORY EFFECTS ON TISSUE FACTOR (TF) PRODUCTION BY MONOCYTES (M) - ROLE OF REACTIVE OXYGEN SPECIES (ROS), Circulation, 98(17), 1998, pp. 586-586
A DOUBLE-BLIND RANDOMIZED COMPARISON OF COMBINED ASPIRIN AND TICLOPIDINE THERAPY VERSUS ASPIRIN OR TICLOPIDINE ALONE ON EXPERIMENTAL ARTERIAL THROMBOGENESIS IN HUMANS
Authors: BOSSAVY JP THALAMAS C SAGNARD L BARRET A SAKARIASSEN K BONEU B CADROY Y
Citation: Jp. Bossavy et al., A DOUBLE-BLIND RANDOMIZED COMPARISON OF COMBINED ASPIRIN AND TICLOPIDINE THERAPY VERSUS ASPIRIN OR TICLOPIDINE ALONE ON EXPERIMENTAL ARTERIAL THROMBOGENESIS IN HUMANS, Blood, 92(5), 1998, pp. 1518-1525
15TH CONGRESS OF GRRC AND CONGRESS OF GEH T, LILLE, APRIL 28TH AND 29TH 1998
Authors: BAUTERS C GOUDEMAND J JUDE B CHARLEMAGNE D BONEU B
Citation: C. Bauters et al., 15TH CONGRESS OF GRRC AND CONGRESS OF GEH T, LILLE, APRIL 28TH AND 29TH 1998, Archives des maladies du coeur et des vaisseaux, 91(4), 1998, pp. 439-439
THE THROMBOMODULIN PROTEIN-C PROTEIN-S ANTICOAGULANT PATHWAY MODULATES THE THROMBOGENIC PROPERTIES OF THE NORMAL RESTING AND STIMULATED ENDOTHELIUM
Authors: CADROY Y DIQUELOU A DUPOUY D BOSSAVY J SAKARIASSEN K SIE P BONEU B
Citation: Y. Cadroy et al., THE THROMBOMODULIN PROTEIN-C PROTEIN-S ANTICOAGULANT PATHWAY MODULATES THE THROMBOGENIC PROPERTIES OF THE NORMAL RESTING AND STIMULATED ENDOTHELIUM, Arteriosclerosis, thrombosis, and vascular biology, 17(3), 1997, pp. 520-527
LONG-TERM PERSISTENCE OF LOW-MOLECULAR-WEIGHT MATERIAL WITH ANTI-FACTOR-XA ACTIVITY CONTRIBUTES TO ANTICOAGULANT AND ANTITHROMBOTIC EFFECTSAFTER SUBCUTANEOUS INJECTION OF CY-216 IN THE RABBIT
Authors: PEYROU V LORMEAU JC HERAULT JP BONEU B HERBERT JM
Citation: V. Peyrou et al., LONG-TERM PERSISTENCE OF LOW-MOLECULAR-WEIGHT MATERIAL WITH ANTI-FACTOR-XA ACTIVITY CONTRIBUTES TO ANTICOAGULANT AND ANTITHROMBOTIC EFFECTSAFTER SUBCUTANEOUS INJECTION OF CY-216 IN THE RABBIT, Blood coagulation & fibrinolysis, 8(3), 1997, pp. 175-184
EFFICACY AND SAFETY OF A LOW-MOLECULAR-WEIGHT HEPARIN AND STANDARD UNFRACTIONATED HEPARIN FOR PROPHYLAXIS OF POSTOPERATIVE VENOUS THROMBOEMBOLISM - EUROPEAN MULTICENTER TRIAL
Authors: KAKKAR VV BOECKL O BONEU B BORDENAVE L BREHM OA BRUCKE P COCCHERI S COHEN AT GALLAND F HAAS S JARRIGE J KOPPENHAGEN K LEQUERREC A PARRAGUETTE E PRANDONI P RODER JD ROOS M RUSCHEMEYER C SIEWERT JR VINAZZER H WENZEL E
Citation: Vv. Kakkar et al., EFFICACY AND SAFETY OF A LOW-MOLECULAR-WEIGHT HEPARIN AND STANDARD UNFRACTIONATED HEPARIN FOR PROPHYLAXIS OF POSTOPERATIVE VENOUS THROMBOEMBOLISM - EUROPEAN MULTICENTER TRIAL, World journal of surgery, 21(1), 1997, pp. 2-9
EFFECT OF HEPARIN ON ARTERIAL THROMBUS FORMATION USING A NEW METHOD FOR QUANTIFYING PLATELETS IN THROMBI FORMED IN FLOWING NATIVE HUMAN BLOOD
Authors: BOSSAVY JP SAKARIASSEN KS BARRET A BONEU B CADROY Y
Citation: Jp. Bossavy et al., EFFECT OF HEPARIN ON ARTERIAL THROMBUS FORMATION USING A NEW METHOD FOR QUANTIFYING PLATELETS IN THROMBI FORMED IN FLOWING NATIVE HUMAN BLOOD, Thrombosis and haemostasis, 1997, pp. 466-466
LIATEST D-D, A NEW FAST ASSAY TO DETERMINE D-DIMERS, HAS PERFORMANCESCOMPARABLE TO CLASSICAL ELISA FOR DIAGNOSIS OF DEEP-VEIN THROMBOSIS
Authors: BONEU B APTEL I NGUYEN F CAMBUS JP THIRION C AMIRAL J BOCCALON H ELIAS A
Citation: B. Boneu et al., LIATEST D-D, A NEW FAST ASSAY TO DETERMINE D-DIMERS, HAS PERFORMANCESCOMPARABLE TO CLASSICAL ELISA FOR DIAGNOSIS OF DEEP-VEIN THROMBOSIS, Thrombosis and haemostasis, 1997, pp. 651-651
ARACHIDONIC-ACID (AA) ENHANCES THE TISSUE FACTOR (TF) EXPRESSION OF MONONUCLEAR-CELLS (MC) BY THE CYCLOXYGENASE-1 (COX-1) PATHWAY - BENEFICIAL EFFECT OF N-3 FATTY-ACIDS (FA)
Authors: CADROY Y DUPOUY D BONEU B
Citation: Y. Cadroy et al., ARACHIDONIC-ACID (AA) ENHANCES THE TISSUE FACTOR (TF) EXPRESSION OF MONONUCLEAR-CELLS (MC) BY THE CYCLOXYGENASE-1 (COX-1) PATHWAY - BENEFICIAL EFFECT OF N-3 FATTY-ACIDS (FA), Thrombosis and haemostasis, 1997, pp. 810-810
TISSUE FACTOR EXPRESSION BY HUMAN VASCULAR SMOOTH-MUSCLE CELLS IS RELATED TO PROLIFERATION - PDGF-INDUCED TF SYNTHESIS IS PREVENTED BY RAISING INTRACELLULAR CAMP
Authors: XUEREB JM SIE P BONEU B CONSTANS J
Citation: Jm. Xuereb et al., TISSUE FACTOR EXPRESSION BY HUMAN VASCULAR SMOOTH-MUSCLE CELLS IS RELATED TO PROLIFERATION - PDGF-INDUCED TF SYNTHESIS IS PREVENTED BY RAISING INTRACELLULAR CAMP, Thrombosis and haemostasis, 1997, pp. 827-827
ENDOGENOUS THROMBIN POTENTIAL AND HEPARIN MONITORING - IN-VITRO AND IN-VIVO STUDIES IN HEALTHY-VOLUNTEERS AND PATIENTS PRESENTING VENOUS THROMBOEMBOLISM
Authors: CAMBUS JP BEGUIN S MISMETTI P DECOUSUS H HEMKER HC BONEU B
Citation: Jp. Cambus et al., ENDOGENOUS THROMBIN POTENTIAL AND HEPARIN MONITORING - IN-VITRO AND IN-VIVO STUDIES IN HEALTHY-VOLUNTEERS AND PATIENTS PRESENTING VENOUS THROMBOEMBOLISM, Thrombosis and haemostasis, 1997, pp. 1134-1134
AGING AND VENOUS THROMBOEMBOLISM INFLUENCE THE PHARMACODYNAMICS OF THE ANTI-XA AND ANTI-IIA ACTIVITIES OF A LOW-MOLECULAR-WEIGHT HEPARIN (NADROPARIN)
Authors: BONEU B MISMETTI P LAPORTE S NAVARRO C SIE P DAZEMAR P NECCIARI J DURET JP GAUD C DECOUSUS H
Citation: B. Boneu et al., AGING AND VENOUS THROMBOEMBOLISM INFLUENCE THE PHARMACODYNAMICS OF THE ANTI-XA AND ANTI-IIA ACTIVITIES OF A LOW-MOLECULAR-WEIGHT HEPARIN (NADROPARIN), Thrombosis and haemostasis, 1997, pp. 1149-1149
COMPARISON OF THE BIOAVAILABILITY OF 2 NADROPARIN FORMULATIONS (10000AND 20000 ANTI-XA IU.ML-1) IN HEALTHY-YOUNG VOLUNTEERS
Authors: BONEU B NAVARRO C CAMBUS JP CAPLAIN H DAZEMAR P NECCIARI J DURET JP GAUD C SIE P
Citation: B. Boneu et al., COMPARISON OF THE BIOAVAILABILITY OF 2 NADROPARIN FORMULATIONS (10000AND 20000 ANTI-XA IU.ML-1) IN HEALTHY-YOUNG VOLUNTEERS, Thrombosis and haemostasis, 1997, pp. 1160-1160
EFFECTS OF LYSOPHOSPHATIDIC ACID, A NOVEL LIPID MEDIATOR, ON CYTOSOLIC CA-MUSCLE CELLS IN CULTURE(+ AND PROLIFERATION OF HUMAN ADULT VASCULAR SMOOTH)
Authors: GENNERO I SIMON MF XUEREB JM GIROLAMI JP BASCANDS JL CHAP H BONEU B SIE P
Citation: I. Gennero et al., EFFECTS OF LYSOPHOSPHATIDIC ACID, A NOVEL LIPID MEDIATOR, ON CYTOSOLIC CA-MUSCLE CELLS IN CULTURE(+ AND PROLIFERATION OF HUMAN ADULT VASCULAR SMOOTH), Thrombosis and haemostasis, 1997, pp. 3030-3030
UP-REGULATION OF TISSUE FACTOR EXPRESSION BY PLATELET-DERIVED GROWTH-FACTOR IN HUMAN VASCULAR SMOOTH-MUSCLE CELLS IN CULTURE - ROLE OF MITOGEN-ACTIVATED PROTEIN-KINASE AND EFFECTS OF INTRACELLULAR CYCLIC-AMP
Authors: XUEREB JM SIE P BONEU B CONSTANS J
Citation: Jm. Xuereb et al., UP-REGULATION OF TISSUE FACTOR EXPRESSION BY PLATELET-DERIVED GROWTH-FACTOR IN HUMAN VASCULAR SMOOTH-MUSCLE CELLS IN CULTURE - ROLE OF MITOGEN-ACTIVATED PROTEIN-KINASE AND EFFECTS OF INTRACELLULAR CYCLIC-AMP, Thrombosis and haemostasis, 78(6), 1997, pp. 1520-1526
THE ACTIVITY OF UNFRACTIONATED HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARINS IN RABBIT PLASMA - THE NEED FOR USING ABSOLUTE ANTI-FACTOR XA AND ANTITHROMBIN ACTIVITIES
Authors: PEYROU V BEGUIN S BONEU B HEMKER HC
Citation: V. Peyrou et al., THE ACTIVITY OF UNFRACTIONATED HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARINS IN RABBIT PLASMA - THE NEED FOR USING ABSOLUTE ANTI-FACTOR XA AND ANTITHROMBIN ACTIVITIES, Thrombosis and haemostasis, 77(2), 1997, pp. 312-316
INCREASED PAI 1 LEVELS ASSOCIATED WITH MODIFICATIONS OF OXIDATIVE SUSCEPTIBILITY IN LDL FROM PATIENTS WITH HYPERTENSION, OBESITY AND OR HYPERINSULINEMIA/
Authors: SOLERA S DOUSSET N GALINIER M LEY N LAGENTE M SOLERA ML BOUNHOURE JP BONEU B VALDIGUIE P
Citation: S. Solera et al., INCREASED PAI 1 LEVELS ASSOCIATED WITH MODIFICATIONS OF OXIDATIVE SUSCEPTIBILITY IN LDL FROM PATIENTS WITH HYPERTENSION, OBESITY AND OR HYPERINSULINEMIA/, Atherosclerosis, 134(1-2), 1997, pp. 319-319
A DOUBLE-BLIND RANDOMIZED COMPARISON OF COMBINED TICLOPIDINE AND ASPIRINE THERAPY VS TICLOPIDINE OR ASPIRINE ALONE ON EXPERIMENTAL ARTERIALTHROMBOGENESIS IN MAN
Authors: BOSSAVY JP THALAMAS C SAGNARD L BARRET A SAKARIASSEN K BONEU B CADROY Y
Citation: Jp. Bossavy et al., A DOUBLE-BLIND RANDOMIZED COMPARISON OF COMBINED TICLOPIDINE AND ASPIRINE THERAPY VS TICLOPIDINE OR ASPIRINE ALONE ON EXPERIMENTAL ARTERIALTHROMBOGENESIS IN MAN, Circulation, 96(8), 1997, pp. 4045-4045
THE PERFORMANCE OF THE KNOWLEDGE-BASED SYSTEM VALAB REVISITED - AN EVALUATION AFTER 5 YEARS
Authors: VALDIGUIE PM ROGARI E CORBERAND JX BONEU B
Citation: Pm. Valdiguie et al., THE PERFORMANCE OF THE KNOWLEDGE-BASED SYSTEM VALAB REVISITED - AN EVALUATION AFTER 5 YEARS, European journal of clinical chemistry and clinical biochemistry, 34(4), 1996, pp. 371-376
PLATELET ANTI-AGGREGATING ACTIVITY AND TOLERANCE OF CLOPIDOGREL IN ATHEROSCLEROTIC PATIENTS
Authors: BONEU B DESTELLE G
Citation: B. Boneu et G. Destelle, PLATELET ANTI-AGGREGATING ACTIVITY AND TOLERANCE OF CLOPIDOGREL IN ATHEROSCLEROTIC PATIENTS, Thrombosis and haemostasis, 76(6), 1996, pp. 939-943
Risultati: 1-25 | 26-50 | 51-66